Top Markets
Coin of the day
Taiwan Advance Bio-Pharmaceutical Inc. Taiwan Advance Bio-Pharmaceutical Inc.

Taiwan Advance Bio-Pharmaceutical Inc.

4186
Pozycja w akcjach #29148
Taiwan Advance Bio-Pharmaceutical Inc. is a biotechnology enterprise with a... Taiwan Advance Bio-Pharmaceutical Inc. is a biotechnology enterprise with a substantial international presence, conducting operations across numerous countries such as China, Germany, the USA, Italy, Malaysia, Vietnam, Thailand, Indonesia, Japan, Korea, and Pakistan, in addition to other global markets. Founded in 1989 and headquartered in New Taipei City, Taiwan, the company delivers a comprehensive array of products and services. Its offerings encompass diagnostic kits for ensuring food safety, alongside tailored customization services for ELISA, rapid, and chemical test kits, and expert consultation for setting up food safety laboratories. The firm also specializes in manufacturing both monoclonal and polyclonal antibody products. Furthermore, its portfolio includes rapid screening tests for illicit substances. It provides essential cell banking services for the secure preservation of both newborn and adult stem cells. The company also operates a dedicated drug testing facility, performing analyses on urine and hair samples to detect and identify drug abuse.
Cena akcji
$0.2518483
Kapitalizacja rynkowa
$22.67M
Zmiana (1 dzień)
-1.61%
Zmiana (1 rok)
-31.34%
Kraj
TW
Handel Taiwan Advance Bio-Pharmaceutical Inc. (4186)

Kategoria

Cena 4186 z kapitalizacją rynkową B
Taiwan Advance Bio-Pharmaceutical Inc. Taiwan Advance Bio-Pharmaceutical Inc.
4186
$0.2518483
Kapitalizacja rynkowa Taiwan Advance Bio-Pharmaceutical Inc.(4186)
Kapitalizacja rynkowa: $22.67M
Na dzień August 2026 spółka Taiwan Advance Bio-Pharmaceutical Inc. ma kapitalizację rynkową wynoszącą $22.67M. Według naszych danych, czyni to Taiwan Advance Bio-Pharmaceutical Inc. 29148th najcenniejszą firmą na świecie pod względem kapitalizacji rynkowej. Kapitalizacja rynkowa to całkowita wartość rynkowa wszystkich wyemitowanych akcji spółki giełdowej i jest powszechnie stosowana do oceny jej wartości.
Historia kapitalizacji rynkowej Taiwan Advance Bio-Pharmaceutical Inc. od 2012 do 2026
4186 w porównaniu do 5 najpopularniejszych stocks
Cena za 4186 Aktywa B Kapitalizacja rynkowa B Wyniki
Taiwan Advance Bio-Pharmaceutical Inc. Taiwan Advance Bio-Pharmaceutical Inc.
$58,894.71 $22.67M
$5.301T +23,384,892.77%
Taiwan Advance Bio-Pharmaceutical Inc. Taiwan Advance Bio-Pharmaceutical Inc.
$51,484.08 $22.67M
$4.634T +20,442,395.84%
Taiwan Advance Bio-Pharmaceutical Inc. Taiwan Advance Bio-Pharmaceutical Inc.
$46,032.11 $22.67M
$4.143T +18,277,613.80%
Taiwan Advance Bio-Pharmaceutical Inc. Taiwan Advance Bio-Pharmaceutical Inc.
$39,879.33 $22.67M
$3.589T +15,834,562.60%
Taiwan Advance Bio-Pharmaceutical Inc. Taiwan Advance Bio-Pharmaceutical Inc.
$31,741.81 $22.67M
$2.857T +12,603,444.05%